当前位置:首页 - 行情中心 - 康华生物(300841) - 财务分析

康华生物

(300841)

  

流通市值:90.97亿  总市值:99.40亿
流通股本:1.19亿   总股本:1.30亿

康华生物(300841)财务分析

净利润 + 每股收益
------
  • 净利润(亿元)
  • 每股收益(元)

    截至第三季度实现净利润1.89亿元,每股收益1.46元。

股东权益 + 未分配利润
------
  • 股东权益(亿元)
  • 未分配利润(亿元)

    截至第三季度最新股东权益350667.25万元,未分配利润244824.86万元。

总资产 + 负债
------
  • 总资产(亿元)
  • 负债(亿元)

    截至第三季度最新总资产393749.62万元,负债43082.37万元。

利润表
报告期2025-09-302025-06-302025-03-312024-12-31
营业总收入840,062,581.82483,918,966.75137,942,758.511,431,876,597.94
营业总成本613,116,128.08348,216,470.57112,232,733.05875,179,262.72
其他经营收益
营业利润221,700,491.66125,538,134.9120,064,411.78467,283,753.56
利润总额221,653,998.38125,497,894.320,057,797.99467,023,387.5
净利润189,110,720.76114,520,580.4920,708,594.7398,651,923.09
每股收益
其他综合收益----
综合收益总额189,110,720.76114,520,580.4920,708,594.7398,651,923.09
资产负债表
报告期2025-09-302025-06-302025-03-312024-12-31
流动资产:
流动资产合计2,416,046,526.852,314,785,612.612,354,274,529.12,488,001,102.09
非流动资产:
非流动资产合计1,521,449,718.361,522,115,413.941,529,393,101.951,539,581,171.88
资产总计3,937,496,245.213,836,901,026.553,883,667,631.054,027,582,273.97
流动负债:
流动负债合计412,879,034.8395,815,671.04406,136,311.95566,368,786.34
非流动负债:
非流动负债合计17,944,692.379,002,977.749,314,028.1213,704,791.35
负债合计430,823,727.17404,818,648.78415,450,340.07580,073,577.69
所有者权益(或股东权益):
归属于母公司股东权益合计3,506,672,518.043,432,082,377.773,468,217,290.983,447,508,696.28
股东权益合计3,506,672,518.043,432,082,377.773,468,217,290.983,447,508,696.28
负债和股东权益合计3,937,496,245.213,836,901,026.553,883,667,631.054,027,582,273.97
现金流量表
报告期2025-09-302025-06-302025-03-312024-12-31
经营活动产生的现金流量:
经营活动现金流入小计874,351,713.06533,225,043.15229,416,043.931,616,032,183.26
经营活动现金流出小计720,626,508.18467,902,555.43246,102,477.91,043,790,285.78
经营活动产生的现金流量净额153,725,204.8865,322,487.72-16,686,433.97572,241,897.48
投资活动产生的现金流量:
投资活动现金流入小计520,388,216.84260,133,867.66260,116,367.66102,432,626.7
投资活动现金流出小计608,071,836.07343,586,357.51331,760,357.62444,299,477.28
投资活动产生的现金流量净额-87,683,619.23-83,452,489.85-71,643,989.96-341,866,850.58
筹资活动产生的现金流量:
筹资活动现金流入小计149,793,800139,793,80059,793,800237,784,905.68
筹资活动现金流出小计322,471,527.63310,225,978.9889,291,703.23709,579,858.07
筹资活动产生的现金流量净额-172,677,727.63-170,432,178.98-29,497,903.23-471,794,952.39
汇率变动对现金及现金等价物的影响55,411.662,092.3664,558.691,767,174.7
现金及现金等价物净增加额-106,580,730.38-188,500,088.75-117,763,768.47-239,652,730.79
期末现金及现金等价物余额693,132,559.99611,213,201.62681,949,521.9799,713,290.37
补充资料:
现金及现金等价物的净增加额--188,500,088.75--239,652,730.79
最新报告期:2025-08-28
研究机构分析师预测每股收益(元)更新日
2025年2026年2027年
西南证券杜向阳3.373.623.862025-08-28
TOP↑